Experience of Using Pentosan Polysulfate SP 54 in Patients with Diabetic Foot Syndrome

Abstract

Diabetic foot — a complex of anatomical and functional changes in the feet caused by diabetic neuropathy leading to osteoarthropathy and angiopathy, against which purulent necrotic processes may develop. Microangiopathy determines basement membrane thickening with deposition in it of PAS-positive substances, endothelial proliferation, leading to circulatory disturbances and, consequently, to the development of thrombosis, embolism, prolonged vasoconstriction. In the treatment for diabetic foot syndrome, heparinoids took leading positions. Application of such heparinoid, as Pentosan polysulfate SP 54, is promising. Its multivector (anticoagulant, fibrinolytic and lipid-lowering) effect on the factor Xa, regardless of antithrombin III, makes it possible to carry out the treatment for diabetic foot syndrome.

Authors and Affiliations

I. V. Nosenko

Keywords

Related Articles

Diabetes Mellitus and Some Microelements

This literature review describes the role of the different trace elements in the development, progression and prevention of diabetes mellitus and its complications. The results of the studies of microelements in blood, u...

Insuman in Disposable Pen SoloStar: New Opportunities of insulin therapy in patients with diabetes mellitus

The article shows the importance of glycemic control in patients with diabetes and the role of insulin in maintaining blood glucose at the right level. The characteristic of modern insulins is given, an emphasis was made...

The role of fractalkine in the development of diabetic macular edema in patients with type 2 diabetes mellitus

Background. Diabetic macular edema (DME) is a severe complication of type 2 diabetes mellitus (DM) and a leading cause of vision loss in the working age population of most developed countries. The gold standard for DME t...

Diabetes mellitus and Alzheimer’s disease

The article reviews modern information on epidemiology and risk factors for Alzheimer’s disease in diabetes mellitus. The literature data on the main pathogenetic links of the development of neurodegenerative disorders i...

Download PDF file
  • EP ID EP229534
  • DOI -
  • Views 47
  • Downloads 0

How To Cite

I. V. Nosenko (2014). Experience of Using Pentosan Polysulfate SP 54 in Patients with Diabetic Foot Syndrome. Міжнародний ендокринологічний журнал, 6(62), 78-82. https://europub.co.uk/articles/-A-229534